awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q50111623-0C59150F-AA4B-431A-A5BE-B4658F5D912F
Q50111623-0C59150F-AA4B-431A-A5BE-B4658F5D912F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50111623-0C59150F-AA4B-431A-A5BE-B4658F5D912F
A Multiple Treatment Comparison of Eleven Disease-Modifying Drugs Used for Multiple Sclerosis.
P2860
Q50111623-0C59150F-AA4B-431A-A5BE-B4658F5D912F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50111623-0C59150F-AA4B-431A-A5BE-B4658F5D912F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8e701808c00cc047f9fcf37e538ce1f46686a881
P2860
Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trial.